Cell-to-cell spread of HIV-1 occurs within minutes and may not involve the participation of virus particles.
暂无分享,去创建一个
D. Dimitrov | J. Orenstein | H. Sato | M. Martin | Hironori Sato | J Orenstein | H Sato | D Dimitrov | M Martin | Malcolma . Martin | M. Martin | Jan Orensteint
[1] T. Klimkait,et al. The human immunodeficiency virus type 1-specific protein vpu is required for efficient virus maturation and release , 1990, Journal of virology.
[2] W. Plunkett,et al. Selective action of 3'-azido-3'-deoxythymidine 5'-triphosphate on viral reverse transcriptases and human DNA polymerases. , 1990, The Journal of biological chemistry.
[3] Y. Okada,et al. Morphological changes in Ehrlich ascites tumor cells during the cell fusion reaction with HVJ (Sendai Virus). I. Alterations of cytoplasmic organelles and their reversion. , 1980, Experimental cell research.
[4] G. Henle,et al. Cytolytic Effects of Mumps Virus in Tissue Cultures of Epithelial Cells.∗ , 1954, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[5] P. Earl,et al. In vitro mutagenesis identifies a region within the envelope gene of the human immunodeficiency virus that is critical for infectivity , 1988, Journal of virology.
[6] K. Steimer,et al. Induction of CD4-dependent cell fusion by the HTLV-III/LAV envelope glycoprotein , 1986, Nature.
[7] J. Levy,et al. Recovery of human immunodeficiency virus from serum. , 1987, JAMA.
[8] H. Lazarus,et al. Continuous culture of human lymphoblasts from peripheral blood of a child with acute leukemia , 1965, Cancer.
[9] T. Uryu,et al. Sulfation of polysaccharides generates potent and selective inhibitors of human immunodeficiency virus infection and replication in vitro. , 1987, Japanese journal of cancer research : Gann.
[10] B. Oberg,et al. Inhibition of HTLV-III/LAV replication by foscarnet. , 1985, Biochemical pharmacology.
[11] K. Strebel,et al. The HIV A (sor) gene product is essential for virus infectivity , 1987, Nature.
[12] Charles F. Johnson,et al. Cytological Studies of Newcastle Disease Virus (NDV) in HEp-2 Cells.∗ , 1964, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[13] A. Notkins,et al. Viral spread in the presence of neutralizing antibody: mechanisms of persistence in foamy virus infection , 1976, Infection and immunity.
[14] H. Gendelman,et al. Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone , 1986, Journal of virology.
[15] A. Collier,et al. Plasma viremia in human immunodeficiency virus infection. , 1989, The New England journal of medicine.
[16] J. Enders,et al. Propagation in Tissue Cultures of Cytopathogenic Agents from Patients with Measles.† , 1954, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[17] Y. Okada,et al. Morphological changes in Ehrlich ascites tumor cells during the cell fusion reaction with HVJ (Sendai virus). II. Cluster formation of intramembrane particles in the early stage of cell fusion. , 1981, Experimental cell research.
[18] Y. Okada. Chapter 10 Sendai Virus-Mediated Cell Fusion , 1988 .
[19] A. Fisher,et al. The sor gene of HIV-1 is required for efficient virus transmission in vitro. , 1987, Science.
[20] A. Notkins,et al. PREVENTION OF CELL-TO-CELL SPREAD OF HERPES SIMPLEX VIRUS BY LEUKOCYTES , 1973, The Journal of experimental medicine.
[21] E. De Clercq,et al. Dextran sulfate and other polyanionic anti-HIV compounds specifically interact with the viral gp120 glycoprotein expressed by T-cells persistently infected with HIV-1. , 1990, Virology.
[22] T. Taguchi,et al. Aphidicolin prevents mitotic cell division by interfering with the activity of DNA polymerase-α , 1978, Nature.
[23] E. De Clercq,et al. Inhibitory effect of dextran sulfate and heparin on the replication of human immunodeficiency virus (HIV) in vitro. , 1987, Antiviral research.
[24] Robin A. Weiss,et al. The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain , 1986, Cell.
[25] R. Cheynier,et al. LAV revisited: origins of the early HIV-1 isolates from Institut Pasteur. , 1991, Science.
[26] B. Oberg,et al. Phosphonoformate inhibits reverse transcriptase. , 1979, The Journal of general virology.
[27] A. Venet,et al. Correlation between CD4 cell counts and cellular and plasma viral load in HIV-1-seropositive individuals. , 1991, AIDS.
[28] R. Weiss,et al. Productive infection and cell-free transmission of human T-cell leukemia virus in a nonlymphoid cell line. , 1983, Science.
[29] B. Sundquist,et al. Phosphonoformate inhibition of visna virus replication , 1979, Journal of virology.
[30] K. Sell,et al. Characterization of a continuous T-cell line susceptible to the cytopathic effects of the acquired immunodeficiency syndrome (AIDS)-associated retrovirus. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[31] R. Ueno,et al. DEXTRAN SULPHATE, A POTENT ANTI-HIV AGENT IN VITRO HAVING SYNERGISM WITH ZIDOVUDINE , 1987, The Lancet.
[32] A. Scheid,et al. Importance of antibodies to the fusion glycoprotein of paramyxoviruses in the prevention of spread of infection , 1980, Journal of Experimental Medicine.
[33] R. Gallo,et al. Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS. , 1984, Science.
[34] J. Albert,et al. REPLICATIVE CAPACITY OF HUMAN IMMUNODEFICIENCY VIRUS FROM PATIENTS WITH VARYING SEVERITY OF HIV INFECTION , 1986, The Lancet.
[35] D. Ho,et al. Quantitation of human immunodeficiency virus type 1 in the blood of infected persons. , 1989, The New England journal of medicine.
[36] L. Callahan,et al. Dextran sulfate blocks antibody binding to the principal neutralizing domain of human immunodeficiency virus type 1 without interfering with gp120-CD4 interactions , 1991, Journal of virology.
[37] F. Sala,et al. Aphidicolin: a specific inhibitor of nuclear DNA replication in eukaryotes , 1982 .
[38] D W Barry,et al. 3'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[39] B. Roizman,et al. The isolation and properties of a variant of Herpes simplex producing multinucleated giant cells in monolayer cultures in the presence of antibody. , 1959, American journal of hygiene.
[40] A. Fauci,et al. Induction of HTLV-III/LAV from a nonvirus-producing T-cell line: implications for latency. , 1986, Science.
[41] B. Hirt. Selective extraction of polyoma DNA from infected mouse cell cultures. , 1967, Journal of molecular biology.
[42] MartinS. Hirsch,et al. INHIBITION OF HUMAN T-CELL LYMPHOTROPIC VIRUS TYPE III IN VITRO BY PHOSPHONOFORMATE , 1985, The Lancet.
[43] J. Albert,et al. Distinct replicative and cytopathic characteristics of human immunodeficiency virus isolates , 1988, Journal of virology.
[44] S. O’Brien,et al. Origin of the HIV-susceptible human CD4+ cell line H9. , 1989, AIDS research and human retroviruses.
[45] Huisman,et al. Differential syncytium-inducing capacity of human immunodeficiency virus isolates: frequent detection of syncytium-inducing isolates in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex , 1988, Journal of virology.
[46] J. Spouge,et al. Blocking of human immunodeficiency virus infection depends on cell density and viral stock age , 1991, Journal of virology.
[47] J. Huberman. New views of the biochemistry of eucaryotic DNA replication revealed by aphidicolin, an unusual inhibitor of DNA polymerase α , 1981, Cell.
[48] J. Levy,et al. Differential ability of human immunodeficiency virus isolates to productively infect human cells. , 1987, Journal of immunology.
[49] C. Cheng‐Mayer,et al. Biologic features of HIV-1 that correlate with virulence in the host. , 1988, Science.
[50] F. Black,et al. Microepidemiology of poliomyelitis and herpes-B infections: spread of the viruses within tissue cultures. , 1955, Journal of immunology.